Pilot study assessment [Study As­sess­ment]

posted by Smog – Russia, 2016-03-24 20:37 (2951 d 23:12 ago) – Posting: # 16136
Views: 5,475

Hello to everybody!

I have a little question regarding the pilot study (2x2x2, 11 subjects). The point estimate for the Cmax was 116.97. CI is: LL 95,28, UL 146,01 in the pilot study. The drug is not HVD.
Is there any sence to go forward with pivotal study in case of such GMR? If so which GMR to use: 0,95 or 1,1697?

Thank you in advance for your help.

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,652 registered users;
74 visitors (1 registered, 73 guests [including 6 identified bots]).
Forum time: 20:50 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5